United States · FDA National Drug Code directory
RIXUBIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0944-3026_1426f595-e663-4c4a-8318-fed3310867f8
- Product NDC
- 0944-3026
- Form
- KIT
- Composition / generic term
- COAGULATION FACTOR IX (RECOMBINANT)
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20131004
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (0944-3026-02) * 5 mL in 1 VIAL, GLASS (0944-3025-01) * 5 mL in 1 VIAL, GLASS (64764-515-50) · 0944-3026-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →